An in-silico study with a molecular modeling approach showed apigetrin, cyanaroside, and cuminum compounds might inhibit CDK8 and PR receptors, indicating potential anti-tumor, anti-proliferative and enzyme inhibitory effects (171). This evidence concerns the gene CDK8 and neoplasm.